The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line
1996
Discovery of the ARA Protein Linked to Drug Resistance in Leukemia
publication
Evidence: moderate
Author Information
Author(s): TJ Longhurst, GM O'Neill, RM Harvie, RA Davey
Primary Institution: University of Technology, Sydney; Royal North Shore Hospital
Hypothesis
The ara gene is associated with multidrug resistance in leukemia cells.
Conclusion
The study identifies a novel protein, ARA, that is overexpressed in a multidrug-resistant leukemia cell line.
Supporting Evidence
- ARA protein is overexpressed in the CCRF-CEM/E1000 leukemia cell line.
- ARA has similarities to the multidrug resistance-associated protein (MRP).
- Both ARA and MRP are amplified in the E1000 subline compared to the parent CEM line.
Takeaway
Scientists found a new protein that helps leukemia cells resist drugs, making it harder to treat cancer.
Methodology
The study involved analyzing mRNA expression and protein characteristics in leukemia cell lines.
Want to read the original?
Access the complete publication on the publisher's website